Testing new drugs and therapies on 3D-printed human organs in a lab could reduce the time and costs of getting a new drug to market
Develop, Protect And Unlock True Value
Write to Us
In today’s business world, your Intellectual Property (IP) is a critical competitive advantage that you have to actively manage, protect and leverage.
As an IP owner or manager you are constantly looking for intelligence and answers to help you get more out of your intellectual property. At Aranca, we understand the challenges faced by you and have customized solutions that help you to manage, protect and drive value of your IP assets across the IP lifecycle.
Our Technology Intelligence & IP Research team delivers tailored solutions covering technology landscape studies, whitespace analysis, patent analytics, prior art searches, patent drafting and research, IP valuation, out-licensing support and litigation support. This doubled with the expertise of our Business Research & Advisory and Valuation Advisory teams help us bring together perspectives that are normally missed by other service providers in this space, when answering key questions to enable your IP strategy decisions.
A trusted partner to 300+ global companies, including
Fortune 500 Companies
Technology Consulting Firms
Universities & Research Institutes
Drive business value and competitive advantage with well-defined R&D and technology strategies.
Maximize value of your IP investments across the patent lifecycle, from protection to monetization.
Are you armed with the right technical evidence when it comes to patent litigation?
Engage With Specialists
Leverage analysts with advanced degrees and deep knowledge your technology domain.
Leverage our methodologies to solve complex tech and IP related strategic questions.
10,000+ projects executed, spanning 250 technology domains and all important IP jurisdictions.
Expert Network Access
We combine internal expertise with the opinions of 10,000+ technology experts to generate insights that matter.
Deep Market Knowledge
Leverage our market intelligence capabilities to strengthen your technology & IP strategies.
We design tailor-made solutions for each client request that address specific issues and budgets.
Benefit from our unique methodologies to answer complex technical and IP related questions.
Patent Quality Index
Framework to assess the quality of patents in a portfolio through a combination of subjective and objective parameters.
Benchmarking tool to assess technology attractiveness based on technical/market and commercialization potential.
Framework for analysis and visual representation of large volumes of scientific information using predefined algorithms.
A robust methodology for valuing patents based on quality/market dynamics and earning attributable to the technical know-how.
Unparalleled Domain Experience
Explore the breadth and depth of our work in different technology domains.
Looking for help with Technology Intelligence, IP Strategy, or Litigation support?
Write to Us
Made-to-order organs could be just round the corner.Organ transplantation is one of medical science’s most complex fields. Besides issues with compatibility, viability, and t
Recently developed radio-pharmaceuticals agents could significantly improve the diagnosis, treatment, and prediction of heart disease.A relatively new diagnostic method, cardiac nuclear imaging involves the
Thousands of patients are waiting for a lifesaving transplant today. Some of these are critical cases, and mortality in those patients is high due to
On June 23, the cross-licensing deal between Cisco and BlackBerry was announced. The agreement was a no-brainer when one considered the current market position of BlackBerry,
Simon Sinek, in his TED Talk ‘How Great Leaders Inspire Action’, makes a prudent point. Interestingly, this very point makes a significant impact on R&D a
Envisaged over a hundred years ago as a steam-powered set of locomotive legs, we’ve come a long way in our quest to seriously suit-up.
We're entering a new era in molecular biology. A new tool based on a bacterial CRISPR-associated protein-9 nuclease (Cas9) from Streptococcus pyogenes will enable the
Conventional options for Cancer treatment are plagued with several issues such as poor water solubility, lack of targeting capability, non-specific distribution, systemic toxicity, and low
The use of intellectual property as collateral to obtain finance is an increasingly common phenomenon. Over the past three decades, the proportion of tangible assets
A healthcare application of IoT technologies, the concept of Internet of Medical Things (IoMT) envisions a network of connected devices that sense vital data in
Recent novel radiopharmaceuticals agents developed to target specific subcellular process are capable of significantly improving diagnostic accuracy and prognostic evaluation. The global nuclear medicine diagnostic
© 2016, Aranca. All rights reserved.
United States | United Kingdom | China | India | Dubai | KSA